Presentation is loading. Please wait.

Presentation is loading. Please wait.

pSS: primary SS; Scl: scleroderma.

Published byFrederick Kelly Modified over 6 years ago

Similar presentations

Presentation on theme: "pSS: primary SS; Scl: scleroderma."— Presentation transcript:

1 pSS: primary SS; Scl: scleroderma.
From: Utility of the American–European Consensus Group and American College of Rheumatology Classification Criteria for Sjögren’s syndrome in patients with systemic autoimmune diseases in the clinical setting Rheumatology (Oxford). 2014;54(3): doi: /rheumatology/keu352 Rheumatology (Oxford) | © The Author Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please

2 AECG: American–European Consensus Group.
From: Utility of the American–European Consensus Group and American College of Rheumatology Classification Criteria for Sjögren’s syndrome in patients with systemic autoimmune diseases in the clinical setting Rheumatology (Oxford). 2014;54(3): doi: /rheumatology/keu352 Rheumatology (Oxford) | © The Author Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please

Download ppt "pSS: primary SS; Scl: scleroderma."

Similar presentations

From: A Regularist Approach to Mechanistic Type-Level Explanation

From: A Regularist Approach to Mechanistic Type-Level Explanation
From: An open day in the metric space

From: An open day in the metric space
Fig. 3. Plot of overall survival by adjuvant therapy for patient subgroups. (A) Patients with M0 disease (n = 411). (B) Patients receiving 36 Gy craniospinal.

Fig. 3. Plot of overall survival by adjuvant therapy for patient subgroups. (A) Patients with M0 disease (n = 411). (B) Patients receiving 36 Gy craniospinal.
Fig. 1 Flow chart of the COBRA-light trial and its extension study

Fig. 1 Flow chart of the COBRA-light trial and its extension study
From: Global Banking: Recent Developments and Insights from Research*

From: Global Banking: Recent Developments and Insights from Research*
Fig. 1 Graphical representation

Fig. 1 Graphical representation
Patients in the no test scenario all enter the model at A, while patients in the test scenario enter the model at either A or B dependent upon test result.

Patients in the no test scenario all enter the model at A, while patients in the test scenario enter the model at either A or B dependent upon test result.
Figure 2. CONSORT flow diagram.

Figure 2. CONSORT flow diagram.
From: Political Leadership and Power Redistribution

From: Political Leadership and Power Redistribution
Test characteristics of MRI-detected inflammation for the development of arthritis in CSA patients (A) and RA in UA patients (B) during 1-year follow-up.

Test characteristics of MRI-detected inflammation for the development of arthritis in CSA patients (A) and RA in UA patients (B) during 1-year follow-up.
Error bars represent the mean (s.e.).

Error bars represent the mean (s.e.).
Figure 1. Selection of papers.

Figure 1. Selection of papers.
Fig. 1 Underestimation and lack of sensitivity of T1-weighted fat-suppressed (FS) SPGR sequence in the assessment of BMLs. (A) Sagital T2-weighted.

Fig. 1 Underestimation and lack of sensitivity of T1-weighted fat-suppressed (FS) SPGR sequence in the assessment of BMLs. (A) Sagital T2-weighted.
Fig. 1 Flow chart of study selection

Fig. 1 Flow chart of study selection
Proportion of patients that met the SRI-5 response criteria (A and C) and reasons for non-response (B and D) in trial 1 (A and B) and trial 2 (C and D).

Proportion of patients that met the SRI-5 response criteria (A and C) and reasons for non-response (B and D) in trial 1 (A and B) and trial 2 (C and D).
Figure 1. Conceptual model of well-being related to involvement in theatre. From: Theatre Involvement and Well-Being, Age Differences, and Lessons From.

Figure 1. Conceptual model of well-being related to involvement in theatre. From: Theatre Involvement and Well-Being, Age Differences, and Lessons From.
Figure 1. Orthodontic set-up and location of LLLT or placebo-laser

Figure 1. Orthodontic set-up and location of LLLT or placebo-laser
Fig. 1 Flow of ascertainment of cases with incident childhood IgA vasculitis reported by four sources From: Incidence of IgA vasculitis in children estimated.

Fig. 1 Flow of ascertainment of cases with incident childhood IgA vasculitis reported by four sources From: Incidence of IgA vasculitis in children estimated.
Fig. 1. Geographic locations of Shenzhen and Dongguan

Fig. 1. Geographic locations of Shenzhen and Dongguan
From: Unmasking Masks in Makkah: Preventing Influenza at Hajj

From: Unmasking Masks in Makkah: Preventing Influenza at Hajj

Similar presentations

Ads by Google